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Background
Stem cell therapy in the heart is limited by an inability to
track transplanted cell survival. To address this limitation,
we used human amnion-derived mesenchymal stem cells
(hAMSCs), which exhibit longer in vivo survival, and
Manganese (Mn2+)-Enhanced MRI (MEMRI), which
enters live stem cells to augment T1 signal. We tested
Mn2+ pre-labeling of hAMSCs in vitro and whether
MEMRI would detect hAMSC survival in mouse myocar-
dium in vivo.
Methods
hAMSCs were isolated from human placentas after IRB
consent. A subset of cells was transduced with a luci-
ferase reporter gene. One group of hAMSCs was
exposed to 1 μM doxorubicin (DOX) for 4 hrs, then
incubated for 48 hrs. The hAMSCs (Healthy & DOX)
were then labeled with increasing concentrations (0.1,
0.5, & 1 mM) of MnCl2 (Sigma, Inc) for 30 min.
Bioluminescence (BLI) was performed after MnCl2
labeling. Cells were pelleted into Eppendorf tubes and
in vitro 3T MRI was performed (SignaHDx, GE, Inc).
For in vivo MEMRI, 0.25 × 106 Healthy and DOX
hAMSCs were pre-labeled with 0.5 mM MnCl2 for 30
min, washed, and pelleted for direct injection into
hindlimb & myocardium. Mice were immediately
imaged using an FGRE-irP sequence: FOV4/ST 1 mm/
TE min/TI 400 ms/NEX4. In vivo MEMRI was
repeated 2 days later, after 250 μl of i.p. MnCl2.
Results
0.5 mM MnCl2 increased the T1 signal and contrast-to-
noise ratio (CNR) of healthy hAMSCs (ΔCNR 80 ± 2*) ~3x
vs DOX hAMSCs (29 ± 2, *p < 0.05) due to BLI-verified
cell dropout. BLI showed no reduction in hAMSC survival
after Mn2+ labeling (Figure 1A). Hindlimb imaging showed
increased MEMRI CNR (18 ± 3) and BLI signal from
pre-labeled hAMSCs (1B). Cardiac MEMRI of Healthy
hAMSCs showed positive signal immediately after delivery
as well as 2 days later (1C). However, DOX hAMSCs
showed no MEMRI signal in vivo.
Conclusions
MEMRI successfully labels and tracks live, transplanted
hAMSCs in the heart, enabling serial tracking of cell
delivery and survival with no genetic pre-modification.
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Figure 1 A: (left): 0.5 mM MnCl2 was sufficient to increase the T1 signal of pre-labeled healthy hAMSCs, but injured/dead DOX
hAMSCs failed to take up MnCl2; (right) BLI shows better survival of hAMSCs 48 hrs after incubation with either 0.1 mM or 0.5 mM
MnCl2, compared to DOX hAMSCs. 1B: (left) Hindlimb MRI showing positive MEMRI signal from pre-labeled hAMSCs in left hindlimb; (right)
corresponding positive BLI signal from same hindlimb, confirming live hAMSCs. 1C: (top) short- (SAX) and long- (LAX) axis MEMRI of mouse heart
immediately post-hAMSC delivery. Note the positive signal in the basal inferior wall (arrow) whereas simultaneous DOX hAMSC injection in
anterior wall shows no MEMRI signal (dotted arrow); (bottom) 2 days after hAMSC delivery, i.p. MEMRI injection reveals intense uptake in basal
inferior wall (healthy hAMSCs, arrow) with no uptake in anterior wall (DOX hAMSCs, dotted arrow).
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